Barriers to MASLD Management in Europe: Findings From a Multidisciplinary HCP-survey (NCT05765890) | Clinical Trial Compass
CompletedNot Applicable
Barriers to MASLD Management in Europe: Findings From a Multidisciplinary HCP-survey
India675 participantsStarted 2023-03-24
Plain-language summary
The purpose of this study is to better understand the main barriers to earlier diagnosis and better management of MASLD/MASH patients and to understand the key barriers to adoption of guidelines.
This study is a cross-sectional design, conducted across 5 countries in Europe- France, Germany, Spain, United Kingdom (UK), Italy. Study participants, Hepatologists and other metabolically focused healthcare providers (HCPs), will be recruited to complete a 15 minute self-administered online survey.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
. Male or female, age above or equal to 18 years at the time of signing informed consent.
. Is a physician
. Lives in UK, France, Germany, Italy or Spain
. Primary medical specialty is:
.a. Hepatology or 5.b. Gastroenterology or Internal Medicine with a subspecialty in Hepatology 6. In practice at least 3 years 7. Spends at least 50 percent of their time in an office/clinic setting 8. Spends at least 60 percent of their time in direct patient care 9. Sees at least 15 patients/month with MASH/MASLD
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Unaided awareness
Timeframe: At the time of survey response (Day 1)
2
Aided awareness
Timeframe: At the time of survey response (Day 1)
3
Behaviours relative to diagnosing and managing MASLD
. Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
. Male or female, age above or equal to 18 years at the time of signing informed consent.
Exclusion criteria
. Previous participation in this study. Participation is defined as having given informed consent in this study
. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation